Genelux (GNLX) Assets Average (2023 - 2026)
Genelux's (GNLX) quarterly Assets Average came in at $25.7 million in Q1 2026, up 16.78% quarter-over-quarter from $22.0 million in Q4 2025.
Genelux (GNLX) Assets Average (2023 - 2026) Analysis & Trends
Genelux's Assets Average history runs 4 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- On a quarterly basis, Assets Average changed N/A year-over-year to $25.7 million in Q1 2026; TTM through Mar 2026 was $25.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $26.9 million, down 14.16% from the prior year.
- Assets Average grew to $25.7 million in Q1 2026 per GNLX's latest filing, from $22.0 million in the prior quarter.
- Across five years, Assets Average topped out at $42.7 million in Q3 2024 and bottomed at $22.0 million in Q4 2025.
- The 4-year median for Assets Average is $29.8 million (2023), against an average of $31.1 million.
- Across the five-year window, Assets Average grew 21.01% in 2024 and plunged 41.3% in 2025, its largest moves.
- Year by year, Assets Average stood at $31.0 million in 2023, then grew by 21.01% to $37.5 million in 2024, then plunged by 41.3% to $22.0 million in 2025, then increased by 16.78% to $25.7 million in 2026.
- Per Business Quant, the three latest GNLX Assets Average figures stand at $25.7 million (Q1 2026), $22.0 million (Q4 2025), and $28.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.30 Bn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 25.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.70 Mn |
| Dec 31, 2025 | 22.01 Mn |
| Sep 30, 2025 | 28.62 Mn |
| Dec 31, 2024 | 37.49 Mn |
| Sep 30, 2024 | 42.72 Mn |
| Jun 30, 2024 | 34.93 Mn |
| Mar 31, 2024 | 26.28 Mn |
| Dec 31, 2023 | 30.98 Mn |